We're giving you more time to shine! 🌟 The submission deadline for our special issue has been extended. Don't miss this opportunity to share your groundbreaking research. Submit now and be part of something extraordinary! 📚
📢 A new preprint from the lab is online today ➡️https://t.co/vPVkBOFwMq
Here we
➡️describe network-level and behavioral alterations in a common form of monogenic autism
➡️probe effect of AAV-mediated gene therapy in rescuing the observed alterations
Mini-thread 🧵
Really proud to be Topic Editor for the special issue “Think Rare: Current Advances on Understanding and Treatment of X-Linked Neurodevelopmental Disorders” to be published in Frontiers in Neuroscience. Now open for submissions. #ThinkRare#neuroscience
https://t.co/epG1i6Loi5
Meet Elena Scaffei, child neurologist and PhD student in neuroscience actively working on the InnovAS project for developing a fNIRS-based biomarker for AS #AngelmanSyndrome
Take a look to our last paper showing the crucial role of parvalbumin neurons in Creatine Transporter Deficiency https://t.co/mcF01UxzQx #RareDisease#Neuroscience
Take a look to our recent paper showing that visually-evoked cortical activity using #fNIRS correlates with #autism traits in healthy children. We also demonstrate the validity of cartoon-based visual stimulation.
https://t.co/LVr7gjZT0F
Today we celebrate #InternationalAngelmanDay, raising awareness worldwide for this rare genetic condition.
Meet us at Istituto Auxologico Italiano in Milan next 18th Feb to talk about nanotechnologies and novel analytical tool for monitoring brain function in AS.
#Cnr_Nano
Ilaria Tonazzini is PI of the project:
@ilat79 is a tenured researcher @Cnr_Nano.
Her research activity is focused on the cure of neurodevelopmental disorders with nanomedicine.
#AngelmanSyndrome#RareDiseases
IOS imaging is a functional imaging technique that uses differences in optical properties between oxygenated and deoxygenated hemoglobin to monitor brain activity. It is being studied as a potential biomarker for #AngelmanSyndrome
This is Chiara De Cesari, she has joined our research group to work on the identification of molecular biomarkers for Angelman Syndrome in the bloodstream.
Go Chiara!
This is another key member of our team, Mariacristina Gagliardi. She collaborates with the NeuroSens group of the CNR-NANO Institute at the NEST Laboratory, dealing with nanostructured materials with applications in nanomedicine and biosensors #AngelmanSyndrome#nanomaterials
Today we present the first member of our team, Sara Chiarugi. She will work on the development and testing of nanoparticles for the delivery of ASOs to the brain #angelmansyndrome#nanomaterials
We are happy to share that our InnovAS project, funded by the International Angelman Syndrome Alliance (ASA) just started. On Dec 14th we had the kickoff meeting at Nanoscience Institute #AngelmanSyndrome#neuroscience#CNR